載入...
Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma
The overall response rates and long-term survival of primary central nervous system lymphoma (PCNSL) are still significantly inferior to the results achieved in similar subtypes of extranodal non-Hodgkin's lymphoma. It is clearly necessary to investigate new therapeutic methods on PCNSL. We enc...
Na minha lista:
| 發表在: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Ltd
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4508147/ https://ncbi.nlm.nih.gov/pubmed/24628986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12252 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|